ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 233 filers reported holding ROYALTY PHARMA PLC in Q3 2021. The put-call ratio across all filers is 0.36 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $886 | -12.6% | 32,636 | -1.1% | 0.01% | -14.3% |
| Q2 2023 | $1,014 | -10.3% | 32,986 | +5.1% | 0.01% | -12.5% |
| Q1 2023 | $1,131 | -7.7% | 31,398 | +1.2% | 0.01% | -11.1% |
| Q4 2022 | $1,226 | -99.9% | 31,027 | +6.4% | 0.01% | -10.0% |
| Q3 2022 | $1,172,000 | -3.9% | 29,168 | +0.6% | 0.01% | +11.1% |
| Q2 2022 | $1,219,000 | +12.6% | 29,006 | +4.4% | 0.01% | +28.6% |
| Q1 2022 | $1,083,000 | +49.2% | 27,795 | +52.5% | 0.01% | +75.0% |
| Q4 2021 | $726,000 | +12.7% | 18,229 | +2.2% | 0.00% | 0.0% |
| Q3 2021 | $644,000 | -5.3% | 17,830 | +7.5% | 0.00% | -20.0% |
| Q2 2021 | $680,000 | +0.1% | 16,580 | +6.5% | 0.01% | 0.0% |
| Q1 2021 | $679,000 | -20.7% | 15,561 | -9.0% | 0.01% | -28.6% |
| Q4 2020 | $856,000 | +42.9% | 17,100 | +20.1% | 0.01% | +40.0% |
| Q3 2020 | $599,000 | – | 14,234 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |